Spanish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

antifungal/cansancio

El enlace se guarda en el portapapeles.
Página 1 desde 60 resultados
CROSS-REFERENCE TO RELATED APPLICATIONS This application is the U.S. national stage of International Patent Application No. PCT/CN2011/079731, filed on Sep. 16, 2011, which claims the benefit of priority under 35 U.S.C. .sctn.119 from the following Chinese patent applications: Chinese Patent

Ergonomic therapeutic massage device

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION This application discloses a device for body massage and in particular an ergonomic therapeutic massage device. BACKGROUND OF TEE INVENTION Massage is the physiologically and psychologically therapeutic manipulation of muscles, tendons, ligaments and cartilage, with the

Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
This application includes as part of its disclosure a biological sequence listing which is being concurrently submitted through EFS-Web. Said biological sequence listing is contained in a file named "56256o1204.txt" which was created on Dec. 15, 2016, and has a size of 238,677 bytes, and is hereby

Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
The sequence listing in the file named "67858o702005.txt" having a size of 238,525 bytes that was created Nov. 25, 2008 is hereby incorporated by reference in its entirety. BACKGROUND OF THE INVENTION Field of the Invention This invention is an extension of Applicants' prior invention disclosed in

Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
This application claims priority to U.S. Ser. No. 12/153,612 filed May 21, 2008, U.S. Ser. No. 12/153,611 filed May 21, 2008, U.S. Ser. No. 12/124,723 filed May 21, 2008, provisional patent application No. 60/924,550, filed May 21, 2007, and provisional patent application No. 60/924,551, filed May

Antagonists of IL-6 to treat cachexia, weakness, fatigue, and/or fever

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies and novel therapies and therapeutic protocols using anti-IL-6 antibodies, preferably those

Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION Field of the Invention This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies and novel therapies and therapeutic protocols using anti-IL-6 antibodies, preferably those

Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and /or fever

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION Field of the Invention This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies and novel therapies and therapeutic protocols using anti-IL-6 antibodies, preferably those

Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
TECHNICAL FIELD The present invention relates to the field of therapeutic uses for erythropoietin, and more particularly, to treating subjects with a recombinant erythropoietin prepared from an Apa I human genomic DNA fragment, including recombinant erythropoietin expressed in transformed baby

Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION The present invention relates to methods for the treatment or prevention of fatigue associated with disordered sleep, for example, in multiple sclerosis, Fabry's disease, fibromyalgia, Parkinson's disease, or traumatic brain injury using cyclobenzaprine. The present invention

Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION The present invention relates to methods for the treatment or prevention of fatigue associated with disordered sleep, for example, in multiple sclerosis, Fabry's disease, fibromyalgia, Parkinson's disease, or traumatic brain injury using cyclobenzaprine. The present invention

Method of treating chronic fatigue syndrome

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to methods of treating individuals suffering from a variety of conditions wherein inhibiting reuptake of norepinephrine provides a benefit. In particular, the present invention relates to methods of treatment

Method of treating chronic fatigue syndrome

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to methods of treating individuals suffering from a variety of conditions wherein inhibiting reuptake of norepinephrine provides a benefit. In particular, the present invention relates to methods of treatment

Therapy platform anti-fatigue matting

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
TECHNICAL FIELD The present invention relates to the field of ergonomic and safety anti-fatigue matting. BACKGROUND OF THE INVENTION Work-related musculoskeletal disorders (MSD) result when there is a mismatch between the physical capacity of workers and the demands of the job. Musculoskeletal

Use of alpha-1-antitrypsin for the preparation of drugs for the treatment of chronic fatigue syndrome

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
The present invention relates to the use of alpha-1-antitrypsin for the preparation of effective drugs for the treatment of chronic fatigue syndrome. BACKGROUND Chronic fatigue syndrome (CFS) is a complex disorder, defined by the international Fukuda criteria (Fukuda K, et al., The chronic fatigue
Únete a nuestra
página de facebook

La base de datos de hierbas medicinales más completa respaldada por la ciencia

  • Funciona en 55 idiomas
  • Curas a base de hierbas respaldadas por la ciencia
  • Reconocimiento de hierbas por imagen
  • Mapa GPS interactivo: etiquete hierbas en la ubicación (próximamente)
  • Leer publicaciones científicas relacionadas con su búsqueda
  • Buscar hierbas medicinales por sus efectos.
  • Organice sus intereses y manténgase al día con las noticias de investigación, ensayos clínicos y patentes.

Escriba un síntoma o una enfermedad y lea acerca de las hierbas que podrían ayudar, escriba una hierba y vea las enfermedades y los síntomas contra los que se usa.
* Toda la información se basa en investigaciones científicas publicadas.

Google Play badgeApp Store badge